Skip to main content
ImmuneCited

Açıklama

Lipidomic profiling of plasma and tissue samples from EPA versus DHA supplementation studies reveals distinct oxylipin and lipid mediator signatures.

Figure 33

Chart

Source Paper

Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?

Nutrients (2020)

PMID: 33276463

DOI: 10.3390/nu12123718

Cite This Figure

![Figure 33: Lipidomic profiling of plasma and tissue samples from EPA versus DHA supplementation studies reveals distinct oxylipin and lipid mediator signatures.]()

> Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." *Nutrients*, 2020. PMID: [33276463](https://pubmed.ncbi.nlm.nih.gov/33276463/)
<figure>
  <img src="" alt="Lipidomic profiling of plasma and tissue samples from EPA versus DHA supplementation studies reveals distinct oxylipin and lipid mediator signatures." />
  <figcaption>Figure 33. Lipidomic profiling of plasma and tissue samples from EPA versus DHA supplementation studies reveals distinct oxylipin and lipid mediator signatures.<br>  Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33276463/">33276463</a></figcaption>
</figure>

İlgili Kanıtlar

A
Omega-3 Fatty Acids (EPA/DHA) için Chronic Inflammation

Derece A · 30 çalışma